hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate
CORTISPORIN (hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate) by Monarch Therapeutics is clinical pharmacology colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Approved for superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics. First approved in 1963.
Drug data last refreshed 21h ago · AI intelligence enriched 1w ago
CORTISPORIN is a triple-combination topical cream containing hydrocortisone acetate (corticosteroid), neomycin sulfate, and polymyxin B sulfate (aminoglycoside and polypeptide antibiotics). It treats superficial bacterial infections of the external auditory canal by combining anti-inflammatory action with broad-spectrum bactericidal coverage against gram-positive and gram-negative organisms. The corticosteroid suppresses inflammation while the antibiotics inhibit bacterial protein synthesis and disrupt cell membranes.
Product approaching loss of exclusivity with limited market data available; brand team likely focused on lifecycle management and generic transition planning rather than growth initiatives.
CLINICAL PHARMACOLOGY Colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Neomycin sulfate is an aminoglycoside antibiotic which inhibits protein synthesis, disrupting the normal cycle of ribosomal function. Hydrocortisone acetate is a…
Worked on CORTISPORIN at Monarch Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on CORTISPORIN offers limited growth upside but provides solid experience in mature product management, generic transition strategy, and cost-effective commercialization. This is better suited to professionals seeking stable roles with established playbooks rather than entrepreneurial launch environments.